{
    "2018-08-20": [
        [
            {
                "time": "",
                "original_text": "东吴医药行业周观点：中报季医药行业价值凸显，重点推荐长春高新、我武生物等消费升级标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报季",
                        "长春高新",
                        "我武生物",
                        "消费升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：调整后，自下而上的机会已愈发显著",
                "features": {
                    "keywords": [
                        "医药行业",
                        "调整",
                        "自下而上",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医保基金收入首次负增长?",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保基金",
                        "收入",
                        "负增长"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业周报：致敬行业变革者，医药长期健康发展趋势不变",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业变革",
                        "长期发展",
                        "健康趋势"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}